info icon

This is a non-core endpoint: only basic statistics are computed.

Dipeptidyl peptidase 4 (DPP-4) inhibitors

DPP4INH

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC A10BG

1 out of 7 registries used, show all original rules.

3812

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

3812

diagram downward connector

Include endpoints None

3812

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3692

diagram downward connector
DPP4INH

Control definitions

Control exclude DIAB_MED_OTHER

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 3692 1504 2188
Unadjusted prevalence (%) 0.90 0.65 1.20
Mean age at first event (years) 59.81 59.07 60.32

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: DPP4INH – Dipeptidyl peptidase 4 (DPP-4) inhibitors
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Dipeptidyl peptidase 4 (DPP-4) inhibitors

Endpoint not on priority list, no data to show.